(Q81957196)
Statements
Daclizumab improves asthma control in patients with moderate to severe persistent asthma: a randomized, controlled trial (English)
William W Busse
Elliot Israel
James W Baker
B Lauren Charous
Donald Y Young
Vladimir Vexler
Richard S Shames
Daclizumab Asthma Study Group
11 September 2008